Literature DB >> 34348325

The Association between Changes in Low Parathyroid Hormone Levels and Cardiac Function Decline in Maintenance Hemodialysis Patients: A Prospective Observational Study.

Xiao-Han Lu1,2, Meng-Si Li1, Yao-Yao Li1, Yan-Dan Zheng1, Xiao-Yan Wu1, Ping Gao1.   

Abstract

OBJECTIVES: The aim of this study was to investigate a possible association between changes in low parathyroid hormone (PTH) levels and cardiac function decline in maintenance hemodialysis (MHD) patients.
METHODS: A total of 150 MHD patients were included and followed for 24 months. The enrolled patients were divided into 3 groups based on their PTH status at baseline and 24 months. Factors potentially involved in changes in the PTH level and cardiac function were compared using multivariate logistic regression analysis.
RESULTS: At 24 months, the presence of low PTH levels increased by 26.7%. The main independent factors for low PTH levels were a low BMI, hemoglobin, and serum albumin and high serum calcium (p < 0.05). A persistently low PTH level at 24 months was associated with a decrease in the left ventricular ejection fraction (LVEF) and increase in valvular calcification (p < 0.05). Additionally, a decrease in PTH levels from normal or high to low values was associated with a decrease in LVEF and cardiac output (CO) and an increase in valvular calcification (p < 0.05). Furthermore, compared with those of the persistently low PTH level group, LVEF values were lower at 24 months in the group with a decrease from high/normal to low PTH level (p < 0.05).
CONCLUSION: Persistently low PTH levels and changes in the PTH level from high/normal to low were associated with cardiac function decline in MHD patients. Moreover, a PTH level change from high/normal to low showed a stronger correlation with cardiac function decline.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiac function; Cardiology; Maintenance hemodialysis; Parathyroid hormone; Renal disease

Mesh:

Substances:

Year:  2021        PMID: 34348325      PMCID: PMC8740217          DOI: 10.1159/000518791

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  22 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

Review 2.  The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications.

Authors:  Antonis Halapas; Evanthia Diamanti-Kandarakis; Demetrios Kremastinos; Michael Koutsilieris
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

3.  Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?

Authors:  Denis Fouque; Hubert Roth; Solenne Pelletier; Gérard M London; Thierry Hannedouche; Guillaume Jean; Jean-Louis Bouchet; Tilman Drüeke
Journal:  Nephrol Dial Transplant       Date:  2012-11-06       Impact factor: 5.992

4.  Cause of Death in Patients with Reduced Kidney Function.

Authors:  Stephanie Thompson; Matthew James; Natasha Wiebe; Brenda Hemmelgarn; Braden Manns; Scott Klarenbach; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2015-03-02       Impact factor: 10.121

5.  Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients.

Authors:  Christiane Drechsler; Diana C Grootendorst; Elisabeth W Boeschoten; Raymond T Krediet; Christoph Wanner; Friedo W Dekker
Journal:  Nephrol Dial Transplant       Date:  2010-09-14       Impact factor: 5.992

6.  Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

Authors:  Manuel Naves-Díaz; Jutta Passlick-Deetjen; Adrian Guinsburg; Cristina Marelli; Jose Luis Fernández-Martín; Diego Rodríguez-Puyol; Jorge B Cannata-Andía
Journal:  Nephrol Dial Transplant       Date:  2010-05-31       Impact factor: 5.992

7.  Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.

Authors:  Emilie Merle; Hubert Roth; Gérard M London; Guillaume Jean; Thierry Hannedouche; Jean-Louis Bouchet; Tilman Drüeke; Denis Fouque; Eric Daugas
Journal:  Kidney Int       Date:  2016-02-02       Impact factor: 10.612

8.  Cognitive function and all-cause mortality in maintenance hemodialysis patients.

Authors:  David A Drew; Daniel E Weiner; Hocine Tighiouart; Tammy Scott; Kristina Lou; Amy Kantor; Li Fan; James A Strom; Ajay K Singh; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2014-09-17       Impact factor: 8.860

Review 9.  Protein Nutrition and Malnutrition in CKD and ESRD.

Authors:  Yan Zha; Qi Qian
Journal:  Nutrients       Date:  2017-02-27       Impact factor: 5.717

Review 10.  Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Authors:  Jaime L Natoli; Rob Boer; Brian H Nathanson; Ross M Miller; Silvia Chiroli; William G Goodman; Vasily Belozeroff
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.